Fluvoxamine + Anagrelide Interaction
Moderateinteraction on record
Description
CYP1A2 inhibitor may increase anagrelide exposure; monitor for cardiovascular events and titrate dose accordingly.
Mechanism
CYP1A2 inhibition
Source: NLP:anagrelide
CYP1A2 inhibitor may increase anagrelide exposure; monitor for cardiovascular events and titrate dose accordingly.
CYP1A2 inhibition
Source: NLP:anagrelide